Phenotype | Overall (nĀ =ā5911) | With seizure history (nĀ =ā616) | Without seizure history (nĀ =ā5295) | History of anticonvulsant use (nĀ =ā1690) | History of brain metastasis (nĀ =ā818) | |||||
---|---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | HR | 95% CI | HR | 95% CI | HR | 95% CI | HR | 95% CI | |
HER2ā/HR+ | 1.00 | Ref. | 1.00 | Ref. | 1.00 | Ref. | 1.00 | Ref. | 1.00 | Ref. |
HER2+/HR- | 1.29** | (1.07, 1.56) | 0.75 | (0.49, 1.16) | 1.38** | (1.12, 1.71) | 1.45* | (1.07, 1.96) | 1.01 | (0.79, 1.30) |
HER2+/HR+ | 1.10 | (0.97, 1.26) | 1.00 | (0.77, 1.31) | 1.12 | (0.97, 1.30) | 1.05 | (0.82, 1.33) | 1.04 | (0.90, 1.22) |
TNBC | 1.35*** | (1.21, 1.52) | 0.99 | (0.78, 1.26) | 1.40*** | (1.23, 1.60) | 1.05 | (0.85, 1.30) | 1.12 | (0.97, 1.29) |